XFOR
X4 Pharmaceuticals Inc
2.80$
-0.7%
vs. previous close
Closing price · As of: Oct 8, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -906.8% | – | -5,377.8% | -6,077.1% | -2,300.9% | -42.9% | -1,515.5% | -1,576.3% | -604.6% | -723.7% | -236.1% | -528.4% | |
| – | 2.0% | – | 34.5% | 50.0% | 19.0% | 1.7% | 18.0% | 12.6% | 8.7% | 8.7% | 11.2% | 10.5% | |
| – | 83.0% | – | 431.3% | 325.0% | 154.6% | 1.8% | 37.9% | 43.1% | 88.4% | 89.1% | 62.4% | 69.1% | |
| – | -175.1% | – | 186.1% | -296.3% | 83.4% | -11.4% | -213.3% | -34.3% | 214.9% | -89.1% | -99.3% | -39.4% | |
| – | 1.1% | – | 23.8% | 16.4% | 2.9% | 10.4% | 0.0% | 170.0% | 116.8% | 723.7% | 222.6% | 285.2% | |
| – | -157.9% | – | 17,204.6% | -2,844.5% | -601.2% | -10.9% | 1,171.4% | -1,624.3% | 656.1% | 710.9% | -11.4% | 40.6% | |
| – | 0.0% | – | – | – | – | – | 2.3% | – | -1.8% | – | – | – | |
| – | – | – | – | 0.0% | 0.0% | – | – | 0.0% | 0.0% | – | – | – | |
| – | 3.2% | – | 3,580.6% | 0.0% | 9.4% | 0.0% | 285.4% | 4,923.8% | 5,688.9% | 0.1% | 0.9% | 1,470.8% | |
| – | -1,057.7% | – | 15,404.1% | -8,893.9% | -2,909.7% | -53.6% | -52.6% | 1,723.1% | 5,740.5% | -34.9% | -240.1% | 982.8% | |
| – | -907.9% | – | -5,401.6% | -6,093.6% | -2,303.8% | -53.3% | -1,515.5% | -1,576.3% | -604.6% | -723.7% | -458.6% | -652.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.